Optas, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Optas, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$574.03 - $680.96 $551,642 - $654,402	-961 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$472.8 - $558.54 $2,364 - $2,792	5 Added 0.52%	961 $537,000
Q1 2021 Apr 19, 2021	BUY	$446.73 - $548.2 $212,643 - $260,943	476 Added 99.17%	956 $452,000
Q4 2020 Jan 27, 2021	SELL	$478.3 - $607.98 $213,800 - $271,767	-447 Reduced 48.22%	480 $232,000
Q3 2020 Oct 23, 2020	BUY	$544.75 - $658.21 $187,394 - $226,424	344 Added 59.01%	927 $519,000

Q2 2020 Jul 31, 2020	SELL	$493.32 - $643.92 $116,423 - $151,965	-236 Reduced 28.82%	583 $363,000
Q1 2020 Apr 14, 2020	BUY	$336.18 - $494.43 $275,331 - $404,938	819 New	819 $400,000

1,427

82.1M

835K

1.46M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $111B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Optas, LLC, based on Form 13F filings with the SEC.

Stay updated on Optas, LLC with notifications on news.